Recall: D-0650-2017

Class III - Minor Violations

Class IIIClassification

2015-12-07Initiated

TerminatedStatus

Lupin Pharmaceuticals Inc.Firm

Product

Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09

Reason

Failed Impurities/Degradation Specifications; Impurity A

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.